Swiss - Delayed Quote CHF

medmix AG (MEDX.SW)

Compare
9.71 -0.05 (-0.51%)
At close: 5:31 PM GMT+1
Loading Chart for MEDX.SW
DELL
  • Previous Close 9.76
  • Open 9.60
  • Bid 9.70 x --
  • Ask --
  • Day's Range 9.56 - 9.80
  • 52 Week Range 9.25 - 19.56
  • Volume 43,220
  • Avg. Volume 73,292
  • Market Cap (intraday) 396.058M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.05
  • Earnings Date --
  • Forward Dividend & Yield 0.50 (5.24%)
  • Ex-Dividend Date Apr 26, 2024
  • 1y Target Est 25.00

medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland.

www.medmix.swiss

2,695

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDX.SW

View More

Performance Overview: MEDX.SW

Trailing total returns as of 11/8/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MEDX.SW
47.20%
MSCI WORLD
19.73%

1-Year Return

MEDX.SW
46.92%
MSCI WORLD
31.42%

3-Year Return

MEDX.SW
75.58%
MSCI WORLD
0.00%

5-Year Return

MEDX.SW
78.14%
MSCI WORLD
26.78%

Compare To: MEDX.SW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDX.SW

View More

Valuation Measures

Annual
As of 11/7/2024
  • Market Cap

    398.10M

  • Enterprise Value

    621.30M

  • Trailing P/E

    1.49k

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.90

  • Price/Book (mrq)

    0.86

  • Enterprise Value/Revenue

    1.30

  • Enterprise Value/EBITDA

    8.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.37%

  • Return on Assets (ttm)

    1.03%

  • Return on Equity (ttm)

    -0.21%

  • Revenue (ttm)

    479.7M

  • Net Income Avi to Common (ttm)

    -1.8M

  • Diluted EPS (ttm)

    -0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    140.7M

  • Total Debt/Equity (mrq)

    77.34%

  • Levered Free Cash Flow (ttm)

    37.14M

Research Analysis: MEDX.SW

View More

Company Insights: MEDX.SW

Research Reports: MEDX.SW

View More

People Also Watch